IN THIS ISSUE

MargaretAnn Cross
Initial results are promising. Employees turn toward preventive medicine and away from expensive drug therapies.
Tony Berberabe
Y2K, 9/11, anthrax scares — these events crystallized the problem of medication stockpiling. How does managed care respond?
Peer-Reviewed
Gailen D. Marshall Jr., MD, PhD
Christine A. Sorkness, PharmD
Omalizumab, a novel therapy that targets specific steps in the inflammatory cascade of asthma, may benefit the hard-to-treat patient.
Legislation & Regulation
John Carroll
Federal backing aligns with market pressure to create an irresistible force. However, health plans need to be aware of some troubling issues.
Ethics
Michael S. Victoroff, MD
It's easy to blame the uninformed, and sometimes fair, but are the ignorant the only ones at fault? Medical professionals need to be able to explain, not just order and direct.
Tomorrow's Medicine
Thomas Morrow, MD
Improvements in the features of diabetes pumps have evolved since their original backpack-size days. Managed care needs to evaluate the new bells and whistles.
Employer Update
MargaretAnn Cross
Pepsi promises that work-site clinics won't take business away from health plans.
News and Commentary